Cite
HARVARD Citation
Steffensen, K. et al. (2017). Veliparib Monotherapy to Patients With BRCA Germ Line Mutation and Platinum-Resistant or Partially Platinum-Sensitive Relapse of Epithelial Ovarian Cancer: A Phase I/II Study. International journal of gynecological cancer. 27 (9), pp. 1842-1849. [Online].